Apyx Medical appoints Stavros Vizirgianakis as Chairman; founder Andrew Makrides retires after 40+ years

Apyx Medical Corp

Andrew Makrides retired as Chairman effective May 7, 2024, after serving since 1982.
Stavros Vizirgianakis appointed Chairman and director to fill vacancy; term expires at 2024 annual meeting.
Vizirgianakis is a former CEO of Misonix and current director of Xtant Medical and Medinotec.
Agreement includes standstill until 2025 annual meeting, limiting ownership to 9.9% and requiring vote with Board.
Board and Vizirgianakis will cooperate to identify an additional director within six months if he holds 5%+ shares.

item 1.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Andrew Makrides

Chairman of the Board

APYX · Apyx Medical Corp

Effective: 2024-05-07
Successor: Stavros Vizirgianakis
Filed: May 9, 2024, 7:59 PM ET

On May 7, 2024, Andrew Makrides announced his retirement as a director and Chairman of the Board, effective on the same date.

Appointed

Stavros Vizirgianakis

Director and Chairman of the Board

APYX · Apyx Medical Corp

Effective: 2024-05-07
Filed: May 9, 2024, 7:59 PM ET

On May 7, 2024, the Board appointed Mr. Vizirgianakis to serve as a director and Chairman of the Board, to fill the vacancy created by the retirement of Andrew Makrides.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Andrew Makrides retired as Chairman of the Board at Apyx Medical Corp.

Action: retired
Role: Chairman of the Board

Exact text from the filing

On May 7, 2024, Andrew Makrides announced his retirement as a director and Chairman of the Board, effective on the same date.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Stavros Vizirgianakis was appointed as Director and Chairman of the Board at Apyx Medical Corp.

Action: appointed
Role: Director and Chairman of the Board

Exact text from the filing

On May 7, 2024, the Board appointed Mr. Vizirgianakis to serve as a director and Chairman of the Board, to fill the vacancy created by the retirement of Andrew Makrides.

View on SEC.gov

Apyx Medical Corp filing history →

Source: SEC EDGAR

accession 0000719135-24-000023

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.